// App-Quantinova.ai

AB0402 : DISEASE ACTIVITY AND OBSESSIVE-COMPULSIVE DISORDER IN SYSTEMIC LUPUS ERYTHEMATOSUS

Researchers

Presenter

  • M. Barraclough

Principal Investigators

  • B. Parker

  • S. Mckie

  • P. Pemberton

  • A. Jackson

  • R. Elliott

  • I. N. Bruce

Medical Centers

  • Centre for Epidemiology Versus Arthritis, The University of Manchester, Manchester, United Kingdom

  • NIHR Manchester BRC, Manchester University NHS FT, MAHSC, Manchester, United Kingdom

  • FBMH Platform Sciences, ET & I, The University of Manchester, Manchester, United Kingdom

  • Manchester University NHS FT, Manchester, United Kingdom

  • WMIC, Institute of Imaging and Bioinformatics, The University of Manchester, Manchester, United Kingdom

  • University of Manchester, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Autoimmune (AI)

Disease

  • Obsessive compulsive disorder

  • Lupus

  • Depression

  • Anxiety

Biomarkers

  • C-C Motif Chemokine Ligand 2

  • Estrogen receptor alpha

  • High sensitivity C-reactive protein

  • Interleukin 6

  • Vascular cell adhesion molecule 1

  • Vascular endothelial growth factor A

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Sanofi Genzyme and The NIHR Manchester Biomedical Research Centre

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved